Related Experiment Video
Updated: Mar 21, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Surgical cure for type 2 diabetes by foregut or hindgut operations: a myth or reality? A systematic review
Yan Mei Goh1, Zaher Toumi2, Ravindra S Date3,4
1Department of Upper Gastrointestinal Surgery, Lancashire Teaching Hospital NHS Foundation Trust, Chorley, PR7 1PP, UK.
Background:
Bariatric surgery results in remission of type 2 diabetes mellitus in a significant proportion of patients. Animal research has proposed the foregut and hindgut hypotheses as possible mechanisms of remission of T2DM independent of weight loss. These hypotheses have formed the basis of investigational procedures designed to treat T2DM in non-obese (in addition to obese) patients. The aim of this study was to review the procedures that utilise the foregut and hindgut hypotheses to treat T2DM in humans.
Methods:
A systematic review was conducted to identify the investigational procedures performed in humans that are based on the foregut and hindgut hypotheses and then to assess their outcomes.
Results:
Twenty-four studies reported novel procedures to treat T2DM in humans; only ten utilised glycated haemoglobin A1c (HbA1c) in their definition of remission. Reported remission rates were 20-40 % for duodenal-jejunal bypass (DJB), 73-93 % for duodenal-jejunal bypass with sleeve gastrectomy (DJB-SG), 62.5-100 % for duodenal-jejunal bypass sleeve (DJBS) and 47-95.7 % for ileal interposition with sleeve gastrectomy (II-SG). When using a predetermined level of HbA1c to define remission, the remission rates were lower (27, 63, 0 and 65 %) for DJB, DJB-SG, DJBS and II-SG.
Conclusions:
The outcomes of the foregut- and hindgut-based procedures are not better than the outcomes of just one of their components, namely sleeve gastrectomy. The complexity of these procedures in addition to their comparable outcomes to a simpler operation questions their utility.
Insights
Foregut and hindgut procedures for type 2 diabetes mellitus (T2DM) show variable remission rates. However, their outcomes are not superior to sleeve gastrectomy alone, questioning their clinical utility.
Area of Science:
- Metabolic surgery
- Gastroenterology
- Endocrinology
Background:
- Bariatric surgery effectively induces type 2 diabetes mellitus (T2DM) remission.
- Foregut and hindgut hypotheses suggest T2DM remission mechanisms independent of weight loss.
- Investigational procedures based on these hypotheses aim to treat T2DM in non-obese and obese patients.
Purpose of the Study:
- To review human procedures utilizing foregut and hindgut hypotheses for T2DM treatment.
- To assess the outcomes of these novel T2DM treatment strategies.
Main Methods:
- Systematic review of studies on investigational procedures for T2DM in humans.
- Identification of procedures based on foregut and hindgut hypotheses.
- Assessment of reported remission rates and outcomes.
Main Results:
- Twenty-four studies reported novel T2DM procedures; only ten used glycated hemoglobin A1c (HbA1c) for remission definition.
- Reported remission rates varied: 20-40% for duodenal-jejunal bypass (DJB), 73-93% for DJB with sleeve gastrectomy (DJB-SG), 62.5-100% for DJB sleeve (DJBS), and 47-95.7% for ileal interposition with sleeve gastrectomy (II-SG).
- Using a predetermined HbA1c level for remission definition yielded lower rates (27%, 63%, 0%, and 65% for DJB, DJB-SG, DJBS, and II-SG, respectively).
Conclusions:
- Foregut and hindgut-based procedures did not demonstrate superior outcomes compared to sleeve gastrectomy alone.
- The complexity of these combined procedures, with comparable outcomes to simpler operations, raises questions about their utility in T2DM management.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Pancreatitis II: Collaborative Care
Assessment:

